Journal
MINI-REVIEWS IN MEDICINAL CHEMISTRY
Volume 15, Issue 6, Pages 467-474Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389557515666150324123208
Keywords
Antagomir; clinical trial; delivery; microRNA; microRNA mimic; therapeutic
Categories
Funding
- NIH [UH2TR000901]
- NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000901, UH3TR000901] Funding Source: NIH RePORTER
Ask authors/readers for more resources
MicroRNAs are short noncoding 18-25 nucleotide long RNA which bind and inhibit mRNA. Currently, there are over 1000 known human microRNAs, and microRNAs control over 50% of mammalian protein coding genes. MicroRNAs can be overexpressed or repressed in different diseases and inhibition or replacement of microRNAs is a promising area of study for therapeutics. Here we review the current knowledge of microRNA therapy, and discuss ways in which they can be utilized. We also discuss different methods of delivery of miRNA, and current clinical trials of microRNA-based therapies for disease. Finally we discuss the current limitations in the field, and how these limitations are being overcome.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available